Elgethun Capital Management increased its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 134.9% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 50,686 shares of the pharmacy operator’s stock after purchasing an additional 29,112 shares during the quarter. Walgreens Boots Alliance accounts for 2.4% of Elgethun Capital Management’s investment portfolio, making the stock its 13th biggest position. Elgethun Capital Management’s holdings in Walgreens Boots Alliance were worth $3,720,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the stock. Victory Capital Management Inc. lifted its position in Walgreens Boots Alliance by 9.5% during the 2nd quarter. Victory Capital Management Inc. now owns 56,749 shares of the pharmacy operator’s stock worth $3,406,000 after acquiring an additional 4,931 shares in the last quarter. D.A. Davidson & CO. lifted its position in Walgreens Boots Alliance by 11.9% during the 2nd quarter. D.A. Davidson & CO. now owns 78,367 shares of the pharmacy operator’s stock worth $4,704,000 after acquiring an additional 8,360 shares in the last quarter. Northern Capital Management LLC lifted its position in Walgreens Boots Alliance by 33.0% during the 2nd quarter. Northern Capital Management LLC now owns 26,500 shares of the pharmacy operator’s stock worth $1,590,000 after acquiring an additional 6,570 shares in the last quarter. Sigma Planning Corp lifted its position in Walgreens Boots Alliance by 29.5% during the 2nd quarter. Sigma Planning Corp now owns 21,441 shares of the pharmacy operator’s stock worth $1,287,000 after acquiring an additional 4,880 shares in the last quarter. Finally, Advanced Asset Management Advisors Inc lifted its position in Walgreens Boots Alliance by 71.2% during the 2nd quarter. Advanced Asset Management Advisors Inc now owns 21,634 shares of the pharmacy operator’s stock worth $1,298,000 after acquiring an additional 9,001 shares in the last quarter. Institutional investors own 62.59% of the company’s stock.

WBA has been the topic of several analyst reports. Zacks Investment Research downgraded Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a report on Monday. Morgan Stanley lifted their price objective on Walgreens Boots Alliance from $55.00 to $77.00 and gave the stock an “equal weight” rating in a report on Monday. BidaskClub upgraded Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a report on Friday, September 28th. Barclays lifted their price objective on Walgreens Boots Alliance from $77.00 to $80.00 and gave the stock an “equal weight” rating in a report on Friday, October 12th. Finally, ValuEngine upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Friday, October 12th. One analyst has rated the stock with a sell rating, twelve have given a hold rating, six have issued a buy rating and two have given a strong buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $78.89.

Shares of NASDAQ WBA opened at $82.82 on Wednesday. Walgreens Boots Alliance Inc has a twelve month low of $59.07 and a twelve month high of $86.31. The company has a quick ratio of 0.38, a current ratio of 0.82 and a debt-to-equity ratio of 0.47. The company has a market capitalization of $80.37 billion, a PE ratio of 13.76, a PEG ratio of 1.34 and a beta of 0.76.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.45 by $0.03. Walgreens Boots Alliance had a return on equity of 21.75% and a net margin of 3.82%. The business had revenue of $33.44 billion during the quarter, compared to the consensus estimate of $33.64 billion. On average, equities analysts forecast that Walgreens Boots Alliance Inc will post 6.54 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 12th. Stockholders of record on Monday, November 12th will be issued a $0.44 dividend. The ex-dividend date of this dividend is Thursday, November 8th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.13%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 29.24%.

In related news, SVP Kimberly R. Scardino sold 11,970 shares of the company’s stock in a transaction on Thursday, November 1st. The stock was sold at an average price of $79.79, for a total transaction of $955,086.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Kathleen Wilson-Thompson sold 52,000 shares of the company’s stock in a transaction on Wednesday, October 31st. The stock was sold at an average price of $78.77, for a total value of $4,096,040.00. Following the transaction, the executive vice president now owns 81,076 shares of the company’s stock, valued at $6,386,356.52. The disclosure for this sale can be found here. Insiders sold a total of 73,756 shares of company stock valued at $5,824,194 over the last quarter. Company insiders own 14.80% of the company’s stock.

WARNING: This piece was first published by Watch List News and is the property of of Watch List News. If you are reading this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this piece can be accessed at https://www.watchlistnews.com/elgethun-capital-management-has-3-72-million-position-in-walgreens-boots-alliance-inc-wba/2662513.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

See Also: Diversification

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.